Current Pharmaceutical Biotechnology


Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens


Become EABM
Become Reviewer

Foreword (“New Targets and New Drugs: from in silico Planning to in vivo Testing”) promotion: free to download

Volume:14   Issue: 5
Pp: 475-476
Giovanni Maga
DOI: 10.2174/138920101405131111103331

Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders

Volume:14   Issue: 5
Pp: 477-487
Marco Radi, Silvia Schenone and Maurizio Botta
DOI: 10.2174/138920101405131111103750

Therapeutic Genes for Anti-HIV/AIDS Gene Therapy

Volume:14   Issue: 5
Pp: 488-500
Chiara Bovolenta, Simona Porcellini and Luca Alberici
DOI: 10.2174/138920101405131111104009

Peptides as Drugs: From Screening to Application

Volume:14   Issue: 5
Pp: 501-512
Ursula Dietrich, Ralf Dürr and Joachim Koch
DOI: 10.2174/13892010113149990205

Capsid Assembly as a Point of Intervention for Novel Anti-viral Therapeutics

Volume:14   Issue: 5
Pp: 513-523
Vishwanath R. Lingappa, Clarence R. Hurt and Edward Garvey
DOI: 10.2174/13892010113149990201

Poly(ADP-ribosylation) and Neoplastic Transformation: Effect of PARP Inhibitors

Volume:14   Issue: 5
Pp: 524-536
Francesca Donà, Ilaria Chiodi, Cristina Belgiovine, Tatiana Raineri, Roberta Ricotti, Chiara Mondello and Anna Ivana Scovassi
DOI: 10.2174/138920101405131111104642

The Power of Enzyme Kinetics in the Drug Development Process

Volume:14   Issue: 5
Pp: 551-560
Alberta Samuele, Emmanuele Crespan, Anna Garbelli, Laura Bavagnoli and Giovanni Maga
DOI: 10.2174/138920101405131111105023

Simple and General Criterion for “in silico” Screening of Candidate HIV Drugs

Volume:14   Issue: 5
Pp: 561-569
Nevena Veljkovic, Sanja Glisic, Jelena Prljic, Vladimir Perovic and Veljko Veljkovic
DOI: 10.2174/138920101405131111105301